{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:26:19Z","timestamp":1786119979752,"version":"build-2736575974"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1097\/inf.0b013e31821ba148","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T03:59:17Z","timestamp":1302753557000},"page":"764-768","source":"Crossref","is-referenced-by-count":24,"title":["Epidemiologic Trends of Cancer Diagnoses Among HIV-infected Children in Spain From 1997 to 2008"],"prefix":"10.1097","volume":"30","author":[{"given":"Alejandro","family":"\u00c1lvaro-Meca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariela","family":"Micheloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Garc\u00eda-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210202","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/QAI.0b013e31817efb54","article-title":"Changes in causes of death among adults infected by HIV between 2000 and 2005: the \u201cMortalite 2000 and 2005\u201d surveys (ANRS EN19 and Mortavic).","volume":"48","author":"Lewden","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R2-10-20210202","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1468-1293.2007.00508.x","article-title":"Trends and determinants of severe morbidity in HIV-infected patients: the ANRS CO3 Aquitaine Cohort, 2000\u20132004.","volume":"8","author":"Bonnet","year":"2007","journal-title":"HIV Med"},{"key":"R3-10-20210202","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.bjc.6605756","article-title":"Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.","volume":"103","author":"Franceschi","year":"2010","journal-title":"Br J Cancer"},{"key":"R4-10-20210202","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1002\/cncr.25311","article-title":"Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies.","volume":"116","author":"Reekie","year":"2010","journal-title":"Cancer"},{"key":"R5-10-20210202","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archinternmed.2010.253","article-title":"Spectrum of cancer risk late after AIDS onset in the United States.","volume":"170","author":"Simard","year":"2010","journal-title":"Arch Intern Med"},{"key":"R7-10-20210202","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/QAD.0b013e3282f47082","article-title":"Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals.","volume":"22","author":"Long","year":"2008","journal-title":"AIDS"},{"key":"R8-10-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0b013e328317cc2d","article-title":"Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.","volume":"23","author":"Crum-Cianflone","year":"2009","journal-title":"AIDS"},{"key":"R9-10-20210202","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QAI.0b013e3181b033ab","article-title":"Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.","volume":"52","author":"Bedimo","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-10-20210202","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa011157","article-title":"Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.","volume":"345","author":"Gortmaker","year":"2001","journal-title":"N Engl J Med"},{"key":"R11-10-20210202","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.284.2.190","article-title":"Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry.","volume":"284","author":"de Martino","year":"2000","journal-title":"JAMA"},{"key":"R12-10-20210202","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.327.7422.1019","article-title":"Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland.","volume":"327","author":"Gibb","year":"2003","journal-title":"BMJ"},{"key":"R13-10-20210202","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/505213","article-title":"Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children.","volume":"43","author":"Resino","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R14-10-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1200\/JCO.2006.06.6506","article-title":"Cancer rates after year 2000 significantly decrease in children with perinatal HIV infection: a study by the Italian Register for HIV Infection in Children.","volume":"25","author":"Chiappini","year":"2007","journal-title":"J Clin Oncol"},{"key":"R16-10-20210202","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jinf.2009.01.002","article-title":"Epidemiology of hospital-treated Salmonella infection; data from a national cohort over a ten-year period.","volume":"58","author":"Gil Prieto","year":"2009","journal-title":"J Infect"},{"key":"R17-10-20210202","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2010.11.025","article-title":"The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003\u20132007).","volume":"29","author":"Gil-Prieto","year":"2011","journal-title":"Vaccine"},{"key":"R18-10-20210202","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.ejca.2006.06.006","article-title":"Cancer in children and adolescents in Europe: developments over 20 years and future challenges.","volume":"42","author":"Pritchard-Jones","year":"2006","journal-title":"Eur J Cancer"},{"key":"R19-10-20210202","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1470-2045(03)00983-5","article-title":"Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS.","volume":"4","author":"Dal Maso","year":"2003","journal-title":"Lancet Oncol"},{"key":"R20-10-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States.","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"key":"R21-10-20210202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/599313","article-title":"Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.","volume":"200","author":"Zoufaly","year":"2009","journal-title":"J Infect Dis"},{"key":"R22-10-20210202","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","article-title":"AIDS-related cancer and severity of immunosuppression in persons with AIDS.","volume":"99","author":"Biggar","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R23-10-20210202","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/QAD.0b013e3282f2705d","article-title":"Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.","volume":"22","author":"Polesel","year":"2008","journal-title":"AIDS"},{"key":"R24-10-20210202","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3851\/IMP1462","article-title":"Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.","volume":"14","author":"Bohlius","year":"2009","journal-title":"Antivir Ther"},{"key":"R25-10-20210202","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/QAD.0b013e328331d384","article-title":"Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy.","volume":"23","author":"van Leeuwen","year":"2009","journal-title":"AIDS"},{"key":"R26-10-20210202","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.inf.0000154324.59426.8d","article-title":"Malignancy in perinatally human immunodeficiency virus-infected children in the United States.","volume":"24","author":"Kest","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R27-10-20210202","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00002030-200202150-00022","article-title":"Immunological recovery after 3 years' antiretroviral therapy in HIV-1- infected children.","volume":"16","author":"Resino","year":"2002","journal-title":"AIDS"},{"key":"R28-10-20210202","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/500412","article-title":"Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.","volume":"42","author":"Resino","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R29-10-20210202","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/CCO.0b013e3282c8c90d","article-title":"AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.","volume":"19","author":"Silverberg","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"R30-10-20210202","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11904-008-0022-4","article-title":"Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era.","volume":"5","author":"Bedimo","year":"2008","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R31-10-20210202","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1542\/peds.112.S1.218","article-title":"Interpreting epidemiologic research: lessons from studies of childhood cancer.","volume":"112","author":"Linet","year":"2003","journal-title":"Pediatrics"},{"key":"R32-10-20210202","doi-asserted-by":"crossref","first-page":"e1470","DOI":"10.1542\/peds.2007-2964","article-title":"Cancer incidence among children and adolescents in the United States, 2001\u20132003.","volume":"121","author":"Li","year":"2008","journal-title":"Pediatrics"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201109000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:29:31Z","timestamp":1786044571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201109000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31821ba148","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.11071956.12024054","asserted-by":"object"}]},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}